Renal Insufficiency Market Expected To Witness Revenue Growth Toward $20.5 Billion By 2030

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Growth In Market Value Is Anticipated For The Renal Insufficiency Market Between 2026 And 2030?

The renal insufficiency market has seen substantial growth in recent years. Its valuation is projected to expand from $12.1 billion in 2025 to $13.48 billion in 2026, reflecting a compound annual growth rate (CAGR) of 11.4%. The historical expansion of this market can be attributed to several factors including the rising prevalence of diabetes and hypertension, the expansion of dialysis center networks, increased use of ACE inhibitors and ARBs, a growing diagnosis of chronic kidney disease, and improved access to renal care services.

The renal insufficiency market is projected for significant expansion in the coming years. This market is anticipated to reach a valuation of $20.51 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 11.1%. The expansion over the forecast period is fueled by factors such as the greater uptake of home dialysis solutions, increased investments in regenerative therapies, the spread of digital patient monitoring, a rising need for individualized renal treatment plans, and an intensified focus on slowing disease progression. Key trends projected for this period encompass the wider adoption of advanced dialysis modalities, a heightened emphasis on managing early stages of the disease, the expanding use of combination drug therapies, the growth of home-based treatment alternatives, and an increased focus on patient-centric care models.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21271&type=smp

What Core Drivers Are Transforming The Renal Insufficiency Market?

The escalating number of high blood pressure and diabetes diagnoses is projected to stimulate the growth of the renal insufficiency market moving forward. These medical conditions are associated with elements such as poor nutritional habits, insufficient physical activity, obesity, inherited susceptibility, and an aging demographic. High blood pressure harms kidney blood vessels by inducing scarring and diminished filtration capabilities, whereas diabetes results in the thickening and overworking of kidney vessels due to elevated blood sugar levels. Both conditions hasten kidney deterioration, ultimately leading to renal insufficiency. For example, a report from the National Health Service in May 2024 indicated that in December 2023, high blood pressure diagnoses in the South East increased by 71,120 patients, representing a 5.4% rise compared to December 2022. Additionally, the British Diabetic Association stated in April 2023 that 4.3 million people in the UK have a diabetes diagnosis. Hence, the increasing instances of high blood pressure and diabetes are propelling the expansion of the renal insufficiency market.

Which Segment-Based Categories Are Covered In The Renal Insufficiency Market?

The renal insufficiency market covered in this report is segmented –

1) By Treatment Type: Medications, Dialysis, Kidney Transplantation, Other Treatment Types

2) By Disease Stage: Chronic Kidney Disease (CKD) Stages, End-Stage Renal Disease (ESRD)

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

4) By End-User: Dialysis Centers, Hospital And Clinics, Research And Academic Institutes

Subsegments:

1) By Medications: Angiotensin-Converting Enzyme (ACE) Inhibitors, Angiotensin II Receptor Blockers (ARBs), Diuretics, Erythropoiesis-Stimulating Agents (ESAs), Phosphate Binders, Sodium Bicarbonate

2) By Dialysis: Hemodialysis, Peritoneal Dialysis, Home Dialysis, Continuous Renal Replacement Therapy (CRRT)

3) By Kidney Transplantation: Living Donor Kidney Transplant, Deceased Donor Kidney Transplant, Kidney Transplant Immunosuppressive Therapy

4) By Other Treatment Types: Lifestyle And Dietary Modifications, Stem Cell Therapy, Gene Therapy

Which Trends Are Contributing To Changes In The Renal Insufficiency Market?

Which Organizations Are Operating Within The Renal Insufficiency Market?

Major companies operating in the renal insufficiency market are Kaiser Permanente, Johnson & Johnson, Roche Holding AG, Sanofi S.A., Abbott Laboratories, Medtronic plc, Amgen Inc., Asahi Kasei Medical Co. Ltd., Fujifilm Holdings Corporation, Fresenius Medical Care, Toray Industries Inc., Baxter International Inc., Boehringer Ingelheim, DaVita Inc., Eisai Co. Ltd., Nipro Corporation, Biocon Limited, HemoCue AB, Rockwell Medical, Mitsubishi Tanabe Pharma Corporation

Access The Complete Renal Insufficiency Market Report:

https://www.thebusinessresearchcompany.com/report/renal-insufficiency-global-market-report

Which Geographic Region Represents The Largest Renal Insufficiency Market Share?

North America was the largest region in the renal insufficiency market in 2025. The regions covered in the renal insufficiency market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Renal Insufficiency Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=21271&type=smp

Browse Through More Reports Similar to the Global Renal Insufficiency Market 2026, By The Business Research Company

Rare Kidney Diseases Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/rare-kidney-diseases-global-market-report

Chronic Kidney Disease Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/chronic-kidney-disease-global-market-report

Veterinary Renal Disease Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-renal-disease-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795